Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Since these programs are physician-supervised, patients receive ongoing guidance and adjustments tailored to their progress, making the results more sustainable than self-directed weight loss efforts
More serious but less common risks include pancreatitis and gallbladder disease
Ivashko-Pachima et al
Based on Lilly's precedent with tirzepatide, retatrutide will likely receive separate brand names for different indications: Tirzepatide became Mounjaro for type 2 diabetes and Zepbound for obesity Retatrutide is expected to follow the same pattern with distinct brand names per indication Brand names are typically announced closer to the FDA approval date or during the NDA review period
US$ 28.48
US$ 23.92
US$ 27.97
US$ 28.52
US$ 25.04
US$ 27.05
US$ 20.36
US$ 24.98
US$ 25.46
